|
ALEXANDRA/IMpassion030: A phase III study of standard adjuvant chemotherapy with or without atezolizumab in early-stage triple-negative breast cancer. |
|
|
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Genentech; Genomic Health; Immunomedics; Lilly; Merck; Pfizer; Spectrum Pharmaceuticals |
Research Funding - Bristol-Myers Squibb (Inst); Lilly (Inst); MedImmune (Inst); Merck (Inst); ZIOPHARM Oncology (Inst) |
Travel, Accommodations, Expenses - Amgen; Genentech; Immunomedics; Lilly; Lilly; Lilly; Lilly; Merck; Pfizer; Puma Biotechnology; Spectrum Pharmaceuticals |
Other Relationship - Lilly; OBI Pharma |
|
|
Consulting or Advisory Role - Celgene; Novartis; Pfizer; Seagen; Tesaro |
Research Funding - Janssen Diagnostics (Inst); Menarini Silicon Biosystems (Inst); Pfizer; Roche (Inst) |
Patents, Royalties, Other Intellectual Property - Patent entitled method for determining sensitivity to a CDK4/6 inhibitor |
Travel, Accommodations, Expenses - Pfizer (I) |
|
|
Research Funding - Roche (Inst) |
Travel, Accommodations, Expenses - Roche |
|
|
No Relationships to Disclose |
|
|
|
Research Funding - AstraZeneca (Inst); Pfizer (Inst); Roche (Inst) |
Travel, Accommodations, Expenses - Roche |
|
|
No Relationships to Disclose |
|
|
|
Research Funding - Abbvie (Inst); Genentech (Inst); Pfizer (Inst); Roche (Inst) |
|
|
Employment - Genentech/Roche |
Stock and Other Ownership Interests - Roche/Genentech |
Research Funding - Genentech/Roche |
|
|
Research Funding - AstraZeneca (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); SERVIER (Inst); Tesaro (Inst) |
|
|
No Relationships to Disclose |
|
|
|
Stock and Other Ownership Interests - Roche |
|
|
Employment - ASIT Biotech |
Research Funding - Genentech; Pfizer (Inst); Roche (Inst) |
Travel, Accommodations, Expenses - Genentech; Roche |
|
|
Research Funding - Roche (Inst) |
Travel, Accommodations, Expenses - Roche |
|
|
Honoraria - MSD Oncology; Pfizer |
Consulting or Advisory Role - Astellas Pharma; Dako; Novartis; Roche/Genentech |
Research Funding - Dako/Agilent Technologies (Inst); Roche/Genentech; Ventana Medical Systems (Inst) |
Travel, Accommodations, Expenses - Celgene; Roche; Roche |
|
|
Research Funding - Roche (Inst) |
Travel, Accommodations, Expenses - Roche |
|
|
No Relationships to Disclose |
|
|
|
|
|
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests - Verastem |
Honoraria - Carrick Therapeutics; Genentech/Roche; GlaxoSmithKline; Lilly; Tesaro |
Consulting or Advisory Role - Leap Therapeutics |
|
|
Research Funding - AstraZeneca (Inst); Celgene (Inst); Ferring (Inst); Ipsen (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst) |